
### [MONDO:0005083](http://purl.obolibrary.org/obo/MONDO_0005083)
**Label:** psoriasis

**Subclasses:** [MONDO:0013057](http://purl.obolibrary.org/obo/MONDO_0013057) (PSORS12), [MONDO:0011084](http://purl.obolibrary.org/obo/MONDO_0011084) (PSORS3), [MONDO:0008251](http://purl.obolibrary.org/obo/MONDO_0008251) (pityriasis rubra pilaris), [MONDO:0013554](http://purl.obolibrary.org/obo/MONDO_0013554) (psoriasis 13, susceptibility to), [MONDO:0011387](http://purl.obolibrary.org/obo/MONDO_0011387) (PSORS4), [MONDO:0012542](http://purl.obolibrary.org/obo/MONDO_0012542) (PSORS8), [MONDO:0011573](http://purl.obolibrary.org/obo/MONDO_0011573) (PSORS7), [MONDO:0014494](http://purl.obolibrary.org/obo/MONDO_0014494) (psoriasis 15, pustular, susceptibility to), [MONDO:0016597](http://purl.obolibrary.org/obo/MONDO_0016597) (generalized pustular psoriasis), [MONDO:0008334](http://purl.obolibrary.org/obo/MONDO_0008334) (psoriasis 1, susceptibility to), [MONDO:0011926](http://purl.obolibrary.org/obo/MONDO_0011926) (PSORS9), [MONDO:0006601](http://purl.obolibrary.org/obo/MONDO_0006601) (pityriasis rosea), [MONDO:0012959](http://purl.obolibrary.org/obo/MONDO_0012959) (PSORS11), [MONDO:0011434](http://purl.obolibrary.org/obo/MONDO_0011434) (PSORS5), [MONDO:0013626](http://purl.obolibrary.org/obo/MONDO_0013626) (psoriasis 14, pustular), [MONDO:0011269](http://purl.obolibrary.org/obo/MONDO_0011269) (psoriasis 2), [MONDO:0006592](http://purl.obolibrary.org/obo/MONDO_0006592) (parapsoriasis), [MONDO:0012896](http://purl.obolibrary.org/obo/MONDO_0012896) (PSORS10), [MONDO:0011542](http://purl.obolibrary.org/obo/MONDO_0011542) (PSORS6), 

**Mapped go classes:** [GO:0042019](http://purl.obolibrary.org/obo/GO_0042019) (interleukin-23 binding), [GO:0015031](http://purl.obolibrary.org/obo/GO_0015031) (protein transport), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0008565](http://purl.obolibrary.org/obo/GO_0008565) (protein transporter activity), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0006886](http://purl.obolibrary.org/obo/GO_0006886) (intracellular protein transport), [GO:0051092](http://purl.obolibrary.org/obo/GO_0051092) (positive regulation of NF-kappaB transcription factor activity), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0016192](http://purl.obolibrary.org/obo/GO_0016192) (vesicle-mediated transport), [GO:0005768](http://purl.obolibrary.org/obo/GO_0005768) (endosome), [GO:0042020](http://purl.obolibrary.org/obo/GO_0042020) (interleukin-23 receptor activity), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0005905](http://purl.obolibrary.org/obo/GO_0005905) (clathrin-coated pit), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0006959](http://purl.obolibrary.org/obo/GO_0006959) (humoral immune response), [GO:0030121](http://purl.obolibrary.org/obo/GO_0030121) (AP-1 adaptor complex), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0030665](http://purl.obolibrary.org/obo/GO_0030665) (clathrin-coated vesicle membrane), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0005143](http://purl.obolibrary.org/obo/GO_0005143) (interleukin-12 receptor binding), [GO:0048305](http://purl.obolibrary.org/obo/GO_0048305) (immunoglobulin secretion), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0002230](http://purl.obolibrary.org/obo/GO_0002230) (positive regulation of defense response to virus by host), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0001783](http://purl.obolibrary.org/obo/GO_0001783) (B cell apoptotic process), [GO:0006896](http://purl.obolibrary.org/obo/GO_0006896) (Golgi to vacuole transport), [GO:0006605](http://purl.obolibrary.org/obo/GO_0006605) (protein targeting), [GO:0030117](http://purl.obolibrary.org/obo/GO_0030117) (membrane coat), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0033209](http://purl.obolibrary.org/obo/GO_0033209) (tumor necrosis factor-mediated signaling pathway), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0001934](http://purl.obolibrary.org/obo/GO_0001934) (positive regulation of protein phosphorylation), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030198](http://purl.obolibrary.org/obo/GO_0030198) (extracellular matrix organization), [GO:0030276](http://purl.obolibrary.org/obo/GO_0030276) (clathrin binding), [GO:0050700](http://purl.obolibrary.org/obo/GO_0050700) (CARD domain binding), 

**Class expressions from DL-Learner:**

- [GO:0030121](http://purl.obolibrary.org/obo/GO_0030121) (AP-1 adaptor complex) 55.00%
- [GO:0005905](http://purl.obolibrary.org/obo/GO_0005905) (clathrin-coated pit) 55.00%
- [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus) 55.00%
- [GO:0030131](http://purl.obolibrary.org/obo/GO_0030131) (clathrin adaptor complex) and [GO:0044431](http://purl.obolibrary.org/obo/GO_0044431) (Golgi apparatus part) 55.00%
- [GO:0030131](http://purl.obolibrary.org/obo/GO_0030131) (clathrin adaptor complex) and [GO:0044431](http://purl.obolibrary.org/obo/GO_0044431) (Golgi apparatus part) and [GO:0044433](http://purl.obolibrary.org/obo/GO_0044433) (cytoplasmic vesicle part) 55.00%
- Thing 52.02%
- [GO:0030131](http://purl.obolibrary.org/obo/GO_0030131) (clathrin adaptor complex) 40.36%
- [GO:0030131](http://purl.obolibrary.org/obo/GO_0030131) (clathrin adaptor complex) and [GO:0044446](http://purl.obolibrary.org/obo/GO_0044446) (intracellular organelle part) 40.36%
- [GO:0030131](http://purl.obolibrary.org/obo/GO_0030131) (clathrin adaptor complex) and [GO:0044433](http://purl.obolibrary.org/obo/GO_0044433) (cytoplasmic vesicle part) 40.36%
- [GO:0030131](http://purl.obolibrary.org/obo/GO_0030131) (clathrin adaptor complex) and [GO:0044422](http://purl.obolibrary.org/obo/GO_0044422) (organelle part) 40.36%
- [GO:0030131](http://purl.obolibrary.org/obo/GO_0030131) (clathrin adaptor complex) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 40.36%
- [GO:0030131](http://purl.obolibrary.org/obo/GO_0030131) (clathrin adaptor complex) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 40.36%
- [GO:0030131](http://purl.obolibrary.org/obo/GO_0030131) (clathrin adaptor complex) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 40.36%
- [GO:0030131](http://purl.obolibrary.org/obo/GO_0030131) (clathrin adaptor complex) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 40.36%
- [GO:0030131](http://purl.obolibrary.org/obo/GO_0030131) (clathrin adaptor complex) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 40.36%


